These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 16929081

  • 1. The Dutch guidelines for treatment with infliximab for Crohn's disease.
    Vermeire S.
    Neth J Med; 2006; 64(7):210-1. PubMed ID: 16929081
    [No Abstract] [Full Text] [Related]

  • 2. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G, Dutch Initiative on Crohn and Colitis (ICC).
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [Abstract] [Full Text] [Related]

  • 3. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR.
    Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract] [Full Text] [Related]

  • 4. [Consensus for infliximab treatment of patients with Crohn's disease].
    van Berge Henegouwen GP.
    Ned Tijdschr Geneeskd; 2000 Sep 16; 144(38):1844-5. PubMed ID: 11020841
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
    Persley K, Scherl E, Rubin P.
    Am J Gastroenterol; 2001 Dec 16; 96(12):3444-5. PubMed ID: 11774971
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prediction of response to infliximab in Crohn's disease.
    Chaudhary R, Ghosh S.
    Dig Liver Dis; 2005 Aug 16; 37(8):559-63. PubMed ID: 15893967
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity of infliximab in Crohn's disease.
    Hanauer SB.
    N Engl J Med; 2003 May 22; 348(21):2155-6; author reply 2155-6. PubMed ID: 12761378
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for the clinical use of infliximab in Crohn's disease.
    Turner SM, Probert CS.
    Rom J Gastroenterol; 2003 Mar 22; 12(1):2-5. PubMed ID: 12673372
    [No Abstract] [Full Text] [Related]

  • 13. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH.
    Z Gastroenterol; 2004 Oct 22; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract] [Full Text] [Related]

  • 14. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
    Meier J, Sturm A.
    Z Gastroenterol; 2009 Feb 22; 47(2):240-2. PubMed ID: 19197829
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment with infliximab in patients with Crohn disease; experience in 132 patients].
    Smits SR, Heijman JA, van Dullemen HM, Rutten WJ, Annemans L, Brouwers JR, Postma MJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1857-8; author reply 1858. PubMed ID: 12382373
    [No Abstract] [Full Text] [Related]

  • 19. Infliximab and the bone in Crohn's disease.
    Kunisaki R, Chaki O, Taguchi T, Sugiyama T, Sugita A.
    Aliment Pharmacol Ther; 2005 Mar 15; 21(6):789-90. PubMed ID: 15771766
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.